[ad_1]
AlphaStreet Newsdesk powered by AlphaStreet Intelligence
Hims & Hers Health shares jumped Wednesday, climbing 6.2% to $37.33 after B of A Securities raised its price target on the telehealth and specialty pharmaceutical company. The upgrade sent volume to 8.8M shares as investors responded to improved sell-side sentiment on the $8.6B market cap stock.
B of A Securities lifted its price target to $37 from $36, a 2.8% increase, while maintaining a Neutral rating. The firm’s new target sits precisely at Wednesday’s closing price, suggesting the analyst views current levels as fair value for the stock. The target raise represents a vote of confidence in the company’s business model, which combines telehealth consultations with direct-to-consumer delivery of generic and specialty medications.
The move comes as Hims & Hers continues to expand its position in the digital health space. The company operates in the Drug Manufacturers – Specialty & Generic industry, offering treatments across multiple therapeutic categories through its subscription-based platform. Wednesday’s analyst action provided a catalyst for shares that had already been building momentum in recent sessions.
Trading volume reflected heightened investor interest in the telehealth name. The 8.8M shares changing hands Wednesday underscored the market’s attention to B of A Securities’ revised outlook. While the Neutral rating suggests a measured view from the analyst, the upward price target adjustment signals improving fundamentals or valuation comfort at current levels.
The stock’s performance Wednesday adds to gains for the specialty pharmaceutical maker as it scales its direct-to-consumer healthcare model. Hims & Hers has carved out a niche in delivering prescription medications and wellness products directly to patients, bypassing traditional pharmacy channels. The company’s approach appeals to consumers seeking convenient access to treatments for conditions ranging from hair loss to sexual health.
What to Watch: Investors should monitor whether additional analysts follow B of A Securities with target adjustments, and watch for any company commentary on subscription trends or new product launches that could drive further upside to Wall Street estimates.
This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.
[ad_2]
Source link